Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic
Hannah R. Mathew, May Y. Choi, Michael D. Parkins, et al.
BMC Pulmonary Medicine (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The efficacy of COVID-19 vaccination in cystic fibrosis patients: a systematic review
Azam Gholami Shahrebabak, Masoud Rezaei, Amirhossein Shahpar, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program
Anurag Verma, Noah L. Tsao, Lauren O. Thomann, et al.
PLoS Genetics (2022) Vol. 18, Iss. 4, pp. e1010113-e1010113
Open Access | Times Cited: 22
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells
Virginia Lotti, Flavia Merigo, Anna Lagni, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1347-1347
Open Access | Times Cited: 18
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
Carla Colombo, Marco Cipolli, Valeria Daccò, et al.
Infection (2021) Vol. 50, Iss. 3, pp. 671-679
Open Access | Times Cited: 24
Food insecurity and mental health during the COVID‐19 pandemic in cystic fibrosis households
J.T. Lim, Ngoc P. Ly, Shaina M. Willen, et al.
Pediatric Pulmonology (2022) Vol. 57, Iss. 5, pp. 1238-1244
Closed Access | Times Cited: 16
Associations and Disease–Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review
Altijana Hromić‐Jahjefendić, Debmalya Barh, Cecília Horta Ramalho Pinto, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 910-910
Open Access | Times Cited: 14
Depression, anxiety, and resilience during COVID‐19 in Dutch patients with cystic fibrosis or primary ciliary dyskinesia and their caregivers
Lieke Noij, Eric G. Haarman, Simone Hashimoto, et al.
Pediatric Pulmonology (2023) Vol. 58, Iss. 7, pp. 2025-2034
Open Access | Times Cited: 8
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Paul J. Baker, Andrea C. Bohrer, Ehydel Castro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People With Cystic Fibrosis
Harriet Corvol, Sandra de Miranda, Clémence Dehillotte, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 12, pp. 2135-2144
Open Access | Times Cited: 11
Lung Transplantation in a New Era in the Field of Cystic Fibrosis
Wei Huang, A. Smith, Maksim Korotun, et al.
Life (2023) Vol. 13, Iss. 7, pp. 1600-1600
Open Access | Times Cited: 6
One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis
Anke Jaudszus, Mariya Pavlova, Marius Rasche, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review
Antonio Vitiello, Michela Sabbatucci, Andrea Silenzi, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
The Impact of COVID-19 in Cystic Fibrosis
Patrick A. Flume, Lisa Saiman, Bruce C. Marshall
Archivos de Bronconeumología (2021) Vol. 58, Iss. 6, pp. 466-468
Open Access | Times Cited: 13
Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis
Athanasios Michos, Filippos Filippatos, Elizabeth‐Barbara Tatsi, et al.
Journal of Cystic Fibrosis (2022) Vol. 21, Iss. 3, pp. e184-e187
Open Access | Times Cited: 9
Patient-Reported Outcomes and Healthcare Practices: A Retrospective Analysis of Cystic Fibrosis Management During the COVID-19 Pandemic
Seyed Ahmad Tabatabaii, Abdolhamid Taghizadeh-Behbahani, Ghamartaj Khanbabaee, et al.
Archives of Pediatric Infectious Diseases (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19
Zakiye Nadeali, Fatemeh Mohammad-Rezaei, Hamid Aria, et al.
Life Sciences (2022) Vol. 297, pp. 120482-120482
Open Access | Times Cited: 8
Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries
Chiara Gabbi, Alessandra Renieri, Birgitta Strandvik
Journal of Infection (2022) Vol. 85, Iss. 3, pp. 318-321
Open Access | Times Cited: 8
Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis
Leonardo Souza Marques, Matheus Negri Boschiero, Nathália Mariana Santos Sansone, et al.
Healthcare (2023) Vol. 11, Iss. 13, pp. 1936-1936
Open Access | Times Cited: 4
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS‐CoV‐2 infection and COVID‐19 disease severity
Philip R. Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 4
Two in one: Overlapping CT findings of COVID-19 and underlying lung diseases
Gamze Durhan, Selin Ardalı Düzgün, Yusuf Baytar, et al.
Clinical Imaging (2022) Vol. 93, pp. 60-69
Open Access | Times Cited: 7
SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far
Carmelo Biondo, Angelina Midiri, Elisabetta Gerace, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2087-2087
Open Access | Times Cited: 6
Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
Virginia Lotti, Anna Lagni, Erica Diani, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Chronic respiratory diseases other than asthma in children: the COVID-19 tsunami
Maria Di Cicco, Maria Giulia Tozzi, Vincenzo Ragazzo, et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2021) Vol. 47, Iss. 1
Open Access | Times Cited: 8
Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis
Nitin Dhochak, Kana Ram Jat, Kapil Soni, et al.
The Indian Journal of Pediatrics (2022) Vol. 89, Iss. 4, pp. 404-406
Open Access | Times Cited: 5
Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes
Paola Medino, Gianfranco Alicandro, Chiara Rosazza, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2771-2771
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top